Ernexa Therapeutics Inc. Warrants
ERNAW
Last
$0.03
Day
-12.5%
1y
-68.1%
5y
-68.1%
52w
-86.0%
SPY YTD
+13.3%
Sec
—
Earnings
—
EMA 21
0.04
EMA 50
0.05
EMA 200
0.07
20d high
-57.4%
5y high
-86.0%
5y range
5th
Positions held
Your positionsERNAW isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$0.06
Stop
$0.01
Stop distance
60.3%
Target vs last
+138.1%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.01 | Beta | 2.65 | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -3.2% | ROA | -105.6% | Debt / equity | 0.11 |
| Current ratio | 2.01 | Free cash flow | -$5.93M | Analyst recommendation | none | Mean target | — |
| 52w high | $0.04 | 52w low | $0.03 |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsERNAW · daily-9.4% over 13 sessions
Close EMA21 EMA50 EMA200